Richtlijn CVRM feb2013 - KNMP

Ridker 2008 Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr, Kastelein JJ, et al. Rosuvastatin
to prevent vascular events in men and women with elevated C-reactive protein ( JUPITER). N
Med 2008; 359: 2195-2207.
Rikitake 2001 Rikitake Y, Kawashima S, Takeshita S, Yamashita T, Azumi H, Yasuhara M, et al. Antioxidative
properties of fluvastatin, an HMG-CoA reductatse inhibitor, contribute to prevention
atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 2001; 154: 87-96.
Eng J
of
Rizos 2012 Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid
supplementation and risk of major cardiovascular disease events: a systematic review and
meta-analysis. JAMA. 2012 Sep 12;308(10):1024-33.
Robinson 2005 Robinson JG, Smith B et al. Pleiotropic effects of statins: benefit beyond cholesterol
reduction A meta-regression analysis. J Am Coll Cardiol 2005; 46: 1855-1862.
Roeters 2011 Roeters van Lennep JE en Mulder MT. Lipoproteine(a) als cardiovasculaire risicofactor. NTvG
2011; 155: 1981-1986.
Ross 1999 Ross R. Atherosclerosis-an inflammatory disease. N Eng J Med 1999; 340: 115-126.
Rossebo 2008 Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K,et al. Intensive lipid
lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 Sep
25;359(13):1343-56.
Rubboli 2005 Rubboli A , Milandri M, Castelvetri C, Cosmi B. Meta-analysis of trials comparing oral
anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for
management of patients with an indication for long-term anticoagulation undergoing
coronary
stenting.Cardiology 2005; 104:101-6.
the
Ruijter de 2009 Ruijter de W, Westendorp RG, Assendelft WJ et al. Use of Framingham risk score and new biomarkers
to predict cardiovascular mortality in older people: population based observational cohort study. BMJ
2009; 338: a3083.
Ryn v 2009 Ryn van J, Sieger P, Kink-Eiband M, et al. Adsorption of dabigatran exetilate in water or dabigatran
in pooled human plasma by activated charcoal in vitro. 51 st ASh Annual Meeting and Exposition. New
Orleans, LA; 2009
Saam 2005 Saam T, Cai JM, Cai YQ et al. Carotid plaque composition differs between ethnoracial groups.
Arterioscler Thromb Vasc Biol 2005; 25: 611-6.
Sacco 2003 Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative
Group. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in
2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003
Dec;26(12):3264-72.
type
Sacco 2008 Sacco RL, Diener HC, Yusuf S, Phil D, Cotton D, Ounpuu S, et al. ( PRoFESS study Group).
Aspirin and extended-relealse dipyridamole versus Clopidogrel for Recurrent Stroke. NEJM 2008;
359: 1238-1251
Saha 2010 Saha SA, Arora RR. Fibrates in the prevention of cardiovascular disease in patients with type 2
diabetes mellitus: a pooled meta-analysis of randomized placebo-controlled clinical trials.
International Journal of Cardiology.2010;141(2):157-166
Santschi 2011 Santschi V, Chiolero A, Burnand B, Colosimo A en Paradis G. Impact of Pharmacist Care in the
Management of Cardiovascular Disease Risk Factors, A Systemic Review and Meta-Analysis of
Randomized Trials. Arch Intern Med 2011; 171: 1441-1453.
Sattar 2010 Sattar N, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of
randomised statin trials. Lancet 2010; 375: 735-742.
Schalekamp 2008 Schalekamp T. Is combinatie van een coumarine plus acetylsalicylzuur/carbasalaatcalcium
rationeel Apothekers Vademecum 2008; 9 (9) .
Schrader 2003
Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS study: evaluation
of acute candesartan cilexetil therapy in stroke survivors. Acute candesartan cilexetil therapy in
stroke survivors study group. Stroke. 2003;34:1699-703.
97
CONCEPT